[1]
J. Bertacchini, “Protein microarray analysis of aberrant signaling pathways in Acute Myeloid Leukemia to predict the patients responsiveness to PI3K/Akt/mTOR inhibitors”, Ital J Anat Embryol, vol. 116, no. 2, p. 22, Nov. 2011.